We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ATXI market cap is 1.99M. The company's latest EPS is USD -0.2681 and P/E is -0.56.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -605k | -663k | -3.91M | -6.43M | -3.92M |
| Net Income | -604k | -662k | 575k | -7.54M | -4.01M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -21.82M | -26.27M | -5.21M | -3.74M | -8.04M |
| Net Income | -21.55M | -25.91M | -5.15M | -3.73M | -3.55M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.01M | 575k | 6.85M | 8.45M | 1.67M |
| Total Liabilities | 407k | 614k | 3.58M | 10.6M | 7.81M |
| Total Equity | 598k | -39k | 3.27M | -2.16M | -6.15M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.53M | 8.92M | 3.25M | 3.96M | 6.85M |
| Total Liabilities | 5.16M | 2.12M | 886k | 509k | 3.58M |
| Total Equity | -631k | 6.8M | 2.36M | 3.45M | 3.27M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.87M | -3.43M | -7.6M | -1.57M | -6.24M |
| Investing | N/A | N/A | N/A | N/A | -2M |
| Financing | N/A | -119k | 10.54M | 3.1M | 3.1M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -18.22M | -26.26M | -4.61M | -3.75M | -7.6M |
| Investing | 10M | N/A | -1M | N/A | N/A |
| Financing | -895k | 32.33M | N/A | 4.38M | 10.54M |
| Market Cap | 1.99M |
| Price to Earnings Ratio | -0.56 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.3 |
| Price to Book Ratio | 0.61 |
| Dividend Yield | - |
| Shares Outstanding | 13.25M |
| Average Volume (1 week) | 5.35M |
| Average Volume (1 Month) | 5.58M |
| 52 Week Change | -90.13% |
| 52 Week High | 2.35 |
| 52 Week Low | 0.14 |
| Spread (Intraday) | 0.01 (3.29%) |
| Company Name | Avenue Therapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.avenuetx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
